[Form 4] Vital Farms, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Vital Farms officer Joanne Bal reported the sale of 9,999 shares of the company's common stock on 08/15/2025 at a weighted average price of $47.70 per share, with transaction prices ranging from $47.60 to $47.81. After the sale, the reporting person beneficially owned 48,128 shares, a total that includes 229 shares acquired under the company's Employee Stock Purchase Plan on 05/15/2025. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing identifies the reporting person as an officer with the title GC, SEC. AND HEAD OF IMPACT.

Positive

• Complete transaction disclosure including exact share count, weighted average price, and price range ( $47.60–$47.81 ).
• Post-transaction holdings clarified with explicit inclusion of 229 ESPP shares acquired on 05/15/2025.
• Commitment to provide per-trade pricing details upon request improves transparency.

Negative

• Officer disposed of 9,999 shares, which may be viewed unfavorably by some investors even though no further context is provided.

Insights

Financial Analyst

TL;DR: An officer sale of 9,999 shares was disclosed; transaction details and remaining holdings are clearly reported.

The Form 4 documents a non-derivative disposition of 9,999 shares by Joanne Bal on 08/15/2025 at a weighted average price of $47.70, with prices in a disclosed range of $47.60 to $47.81. The report also states the reporting person retains 48,128 shares following the sale, which explicitly includes 229 shares acquired via the Employee Stock Purchase Plan on 05/15/2025. The filing provides a footnote committing to provide per-trade pricing details upon request, which enhances transparency. No other executions, derivative transactions, or changes to compensation arrangements are disclosed in this filing.

Corporate Governance Expert

TL;DR: Disclosure is complete for the reported sale and includes provenance of residual shares, meeting Form 4 requirements.

The Form 4 identifies the reporting person's relationship to the issuer and provides the required details for the sale: transaction date, quantity sold, weighted average price, and post-transaction beneficial ownership. The inclusion of the ESPP-acquired 229 shares and the footnote about price breakdowns indicates attention to disclosure detail. The form is executed by an attorney-in-fact and dated 08/19/2025, satisfying signature formalities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bal Joanne

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE, SUITE C100

(Street)

AUSTIN TX 78704

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC, SEC. AND HEAD OF IMPACT

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		S		9,999	D	$47.7(1)	48,128(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.60 to $47.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. Includes 229 shares that were acquired on May 15, 2025 under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

	/s/ Francis Cullo, Attorney-in-Fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Vital Farms (VITL) officer Joanne Bal report on Form 4?

The filing reports a sale of 9,999 shares on 08/15/2025.

At what price were the shares sold in the VITL Form 4 filing?

The shares were sold at a weighted average price of $47.70 per share with individual trade prices ranging from $47.60 to $47.81.

How many Vital Farms shares does the reporting person own after the reported sale?

The reporting person beneficially owned 48,128 shares following the transaction.

Does the Form 4 identify the reporting person's role at Vital Farms?

Yes; the filing lists the reporting person as an Officer with the title GC, SEC. AND HEAD OF IMPACT.

Are there any shares acquired under an employee plan included in the reported holdings?

Yes; the post-transaction total includes 229 shares acquired under the Employee Stock Purchase Plan on 05/15/2025.

When was the Form 4 signed and filed?

The signature on the form is dated 08/19/2025 and executed by an attorney-in-fact.